Kelly Chin
Director, Pulmonary Clinical Research Unit · University of Texas Southwestern Medical Center
Credentials: · · · ·
History
PresentPulmonary Clinical Research Unit · University of Texas Southwestern Medical Center
- Present
University Hospital Heart & Lung Clinic · University of Texas Southwestern Medical Center
- 2005–2007
Pulmonary Disease
1988–1992
Research
Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology
Review · Journal of the American College of Cardiology · 2013 · 822 citations
Selexipag for the Treatment of Pulmonary Arterial Hypertension
New England Journal of Medicine · 2015 · 813 citations
Review · European Respiratory Journal · 2019 · 475 citations
- VM
39 papers
33 papers
- VT
18 papers
16 papers · 9 as a resident
14 papers
- HG
14 papers · 2 as a fellow
- LR
12 papers
12 papers
Grants
- 2013–2018
The Serotonin Transporter in Pulmonary Arterial Hypertension
National Heart, Lung, and Blood Institute · K23
Contact PI · $558.6K · Ut Southwestern Medical Center
Clinical trials
- 2013–2018
Fluoxetine in Pulmonary Arterial Hypertension (PAH) Trial
Principal investigator · Completed · Phase 2
University of Texas Southwestern Medical Center
- 2009–2011
Safety and Efficacy of Fluoxetine in Pulmonary Arterial Hypertension
Principal investigator · Completed · Phase 2
University of Texas Southwestern Medical Center
- 2009–2014
Safety and Efficacy Trial to Treat Diastolic Heart Failure Using Ambrisentan
Principal investigator · Terminated · Phase 4
University of Texas Southwestern Medical Center